Stamoulis Christiana (CIK 1502917) reported 14 SEC Form 4 insider transactions across 3 companies over the past 18 months (most recent 2026-04-09). Recent activity: Sell HOLX (50,526 shares), Buy HOLX (3,190 shares), Sell NONE (18,631 shares), Buy NONE (30,335 shares), Buy HOLX (7,402 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-04-09 | HOLOGIC INC (HOLX) | Director | Sell | 50,526 | $0 |
| 2026-03-02 | HOLOGIC INC (HOLX) | Director | Buy | 3,190 | $0 |
| 2025-12-23 | Keenova Therapeutics plc (NONE) | President and CFO | Sell | 18,631 | $0 |
| 2025-12-17 | Keenova Therapeutics plc (NONE) | President and CFO | Buy | 30,335 | $0 |
| 2025-10-22 | HOLOGIC INC (HOLX) | Director | Buy | 7,402 | $266,768 |
| 2025-10-22 | HOLOGIC INC (HOLX) | Director | Sell | 7,402 | $540,864 |
| 2025-07-16 | INCYTE CORP (INCY) | EVP & Chief Financial Officer | Sell | 1,407 | $98,462 |
| 2025-07-16 | INCYTE CORP (INCY) | EVP & Chief Financial Officer | Sell | 1,445 | $98,621 |
| 2025-07-16 | INCYTE CORP (INCY) | EVP & Chief Financial Officer | Buy | 11,107 | $0 |
| 2025-07-07 | INCYTE CORP (INCY) | EVP & Chief Financial Officer | Sell | 11,589 | $790,022 |
| 2025-04-03 | INCYTE CORP (INCY) | EVP & Chief Financial Officer | Buy | 18,598 | $0 |
| 2025-04-03 | INCYTE CORP (INCY) | EVP & Chief Financial Officer | Buy | 18,970 | $0 |
| 2025-02-28 | HOLOGIC INC (HOLX) | Director | Buy | 1,864 | $0 |
| 2025-01-17 | INCYTE CORP (INCY) | EVP & Chief Financial Officer | Sell | 3,672 | $266,073 |
Source: SEC Form 4 filings · as of 2026-04-09